Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through the following segments: EasyDNA, AffinityDNA, and GeneType/Corporate. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment deals with AffinityDNA branded test sales and expenses. The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987, and is headquartered in Maroochydore, Australia.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for Genetic Technologies Ltd. - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Genetic Technologies Ltd. - ADR 52 week high is $0.765 as of April 10, 2026.
What is the 52-week low for Genetic Technologies Ltd. - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Genetic Technologies Ltd. - ADR 52 week low is $0.765 as of April 10, 2026.
What is Genetic Technologies Ltd. - ADR stock price today?
Genetic Technologies Ltd. - ADR stock price today is $0.765.
What was Genetic Technologies Ltd. - ADR stock price yesterday?
Genetic Technologies Ltd. - ADR stock price yesterday was $0.78.
What is the 50-day moving average of Genetic Technologies Ltd. - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Genetic Technologies Ltd. - ADR 50-day moving average is $0.765.